1. Barnhill RL, Crowson NA, Magro CM and Perpkorn MW. Dermatopathology. Third Edition. The McGraw-Hill Companies, Inc. 2010.
  2. Berliner JG, McCalmont TH, Price VH and Berger TG. Frontal fibrosing alopecia and lichen planus pigmentosus. J Am Acad Dermatol.2014 Jul;71(1):e26-7. doi: 10.1016/j.jaad.2013.12.031.
  3. Calonje E, Brenn T, Lazar A and McKee PH. McKee’s Pathology of the skin with clinical correlations. Fourth Edition. Sunders – Elsevier Inc. St. Louis, Missouri – USA,
  4. Chan, MP. Alopecia: review and update. https://www.pathcme.com/wp-content/uploads/2018/10/CHAN_Alopecia_10-29-18.pdf
  5. Elder DE, Elenitsas R, Johnson Jr. BL, Murphy GF and Xu X. Lever’s histopathology of the skin. Philadelphia – USA: Lippincott Williams & Wilkins, Tenth ed., 2009.
  6. Griggs, J., Trüeb, R. M., Reis Gavazzoni Dias, M. F., Hordinsky, M., & Tosti, A. (2020). Fibrosing Alopecia in a Pattern Distribution. Journal of the American Academy of Dermatology.https://doi.org/10.1016/j.jaad.2019.12.056.
  7. Rezende JM. Linguagem Médica, 3ª edição, pág. 50, 2004, AB editora.
  8. BOSMAN, F. et al.WHO Classification of Tumours of the Digestive System. 4 ed. Lyon: IARC, 2010.
  9. GOLDBLUM JR. et al. Rosai and Ackerman’s: Surgical Pathology. 11 ed. Philadelphia: Editora Elsevier, 2018.
  10. AMIN, MB. et al. AJCC Cancer Staging Manual. 8 ed. Chicago: Springer, 2017.
  11. VALASEK, MA.; PAI, RK. An update on the diagnosis, grading, and staging of appendiceal mucinous neoplasms. Advances in anatomic pathology, v. 25, n. 1, p. 38-60, 2018.
  12. STRICKLAND, S; PARRA-HERRAN, C. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT‐rich sequence‐binding protein 2 in their distinction from primary ovarian mucinous tumours. Histopathology, v. 68, n. 7, p. 977-987, 2016.
  13. Rekhtman N. Neuroendocrine tumors of the lung: an update. Archives of Pathology and Laboratory Medicine. 2010 Nov;134(11):1628-38.
  14. Agaimy A, Fuchs F, Moskalev EA, Sirbu H, Hartmann A, Haller F. SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1 neg/CK7 pos/HepPar-1 pos immunophenotype. Virchows Archiv. 2017 Nov 1;471(5):599-60.
  15. Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Modern Pathology. 2014 Mar;27(3):390.
  16. Louis, David N., et al. “The 2016 World Health Organization classification of tumors of the central nervous system: a summary.” Acta neuropathologica 131.6 (2016): 803-820.
  17. Perry, Arie, and Daniel J. Brat. Practical Surgical Neuropathology: A Diagnostic Approach E-Book: A Volume in the Pattern Recognition Series. Elsevier Health Sciences, 2017.
  18. Kleinschmidt-DeMasters, Bette K., Tarik Tihan, and Fausto Rodriguez. Diagnostic Pathology: Neuropathology E-Book. Elsevier Health Sciences, 2016.
  19. Goldblum, John R., et al. Rosai and Ackerman’s Surgical Pathology E-Book. Elsevier Health Sciences, 2017.
  20. Grignon DJ, Al-Ahmadie H, Algaba F, Amin MB, Comperat E, Dyrskjt L, Epstein JI, Hansel DE, Knuchel R, Lloreta J, Lope z-Beltran A, McKenney JK, Netto GJ, Paner G, Reuter VE, Shen SS, Van der Kwast T. Tumours of the urinary tract. In: Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed. Lyon, France: IARC; 2016.
  21. Zhou M, Netto GJ, Epstein JI. Uropathology: high-yield pathology. Philadelphia, PA: Elseviers Saunders; 2012.
  22. Jonathan I. Epstein, George J. Netto. Differential diagnoses in surgical pathology: genitourinary system. Philadelphia, PA: Lippincott Williams & Wilkins; 2014.
  23. Aydin H, Young RH, Ronnett BM, Epstein JI. Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell carcinoma. Am J Surg Pathol. 2005 Apr;29(4):520-3. PubMed PMID: 15767808.
  24. Odrzywolski KJ, Mukhopadhyay S. Papillary cystadenoma of the epididymis. Arch Pathol Lab Med. 2010 Apr;134(4):630-3. doi: 10.1043/1543-2165-134.4.630. PubMed PMID: 20367315.
  25. Cox R, Vang R, Epstein JI. Papillary cystadenoma of the epididymis and broad ligament: morphologic and immunohistochemical overlap with clear cell papillary renal cell carcinoma. Am J Surg Pathol. 2014 May;38(5):713-8. doi: 10.1097/PAS.0000000000000152. PubMed PMID: 24441657.
  26. Zou ZJ, Xiao YM, Liu ZH, Zhang RC, Liang JY, Tang YQ, Lu YP. Clinicopathological Characteristics, Treatment, and Prognosis of Rarely Primary Epididymal Adenocarcinoma: A Review and Update. Biomed Res Int. 2017;2017:4126740. doi: 10.1155/2017/4126740. Epub 2017 Dec 20. Review. PubMed PMID: 29423406; PubMed Central PMCID: PMC5750466.
  27. Akhtar M, Al-Bozom IA, Al Hussain T. Molecular and Metabolic Basis of Clear Cell Carcinoma of the Kidney. Adv Anat Pathol. 2018 May;25(3):189-196. doi: 10.1097/PAP.0000000000000185. Review. PubMed PMID: 29465421.
  28. Ángel Lazo-Valladares, Marco Fallas-Muñoz, Eduardo Alfaro-Alcocer. Carcinoma metaplásico de mama. Revisión de 6 casos diagnosticados en el Hospital México, durante el período 2000-2006. Acta méd. costarric vol.49 n.4 San José Oct. 2007. Disponível em: On-line version ISSN 0001-6002Print version ISSN 0001-6012. http://www.pathologyoutlines.com/topic/breastmalignantmetaplastic.html
  29. Chhieng C1, Cranor M, Lesser ME, Rosen PP. Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements. Am J Surg Pathol. 1998 Feb;22(2):188-94.
  30. Leddy R1, Irshad A, Rumboldt T, Cluver A, Campbell A, Ackerman S. Review of metaplastic carcinoma of the breast: imaging findings and pathologic features. J Clin Imaging Sci. 2012;2:21. doi: 10.4103/2156-7514.95435. Epub 2012 Apr 28.
  31. Jennifer M. Fu, MD; Tim McCalmont, MD; Siegrid S. Yu, MD. Adenosquamous Carcinoma of the SkinA Case Series.Arch Dermatol. 2009;145(10):1152-1158. doi:10.1001/archdermatol.2009.218.
  32. HORNICK, J. L. Practical Soft Tissue Pathology: A Diagnostic Approach: A Volume in the Pattern Recognition Series. Elsevier Health Sciences, 2017.
  33. HORNICK, J. L. Subclassification of pleomorphic sarcomas: How and why should we care? Annals of diagnostic pathology, v. 37, p. 118-124, 2018.
  34. LINDENBERG, M.R. Diagnostic Pathology: Soft Tissue Tumors. Amirsys Publishing, Inc, 2016.
  35. MIETTINEN, M. Modern soft tissue pathology: tumors and non-neoplastic conditions. Cambridge University Press, 2016.
  36. MIETTINEN, M. et al. New fusion sarcomas: histopathology and clinical significance of selected entities. Human pathology, v. 86, p. 57-65, 2019.
  37. MOHAMED, M.; FISHER, C.; THWAY, K. Low-grade fibromyxoid sarcoma: clinical, morphologic and genetic features. Annals of diagnostic pathology, v. 28, p. 60-67, 2017.
  38. NISHIO, J. et al. Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas. Genet Res Int, v. 2011, p. 497148, 2011.
  39. RIDDLE, N. D.; GARDNER, J. M. The pale blue slide: avoiding myx-ups and mishaps in cutaneous myxoid tumors. Diagnostic Histopathology, v. 22, n. 4, p. 152-166, 2016.
  40. Gamboni M., Miziara E. F. – Manual de Citopatologia Diagnóstica, Sociedad latinoamericana de Citopatología, Editora Manole, 2013.
Referências de edições anteriores